Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2021/12/2 申報
- 申報編號
- 0001883850-21-000016
- 申報時間
- 2021/12/2
- 交易日
- 2021/11/16-12/1
- 申報延遲
- 16 天遲報
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 12 筆非衍生性交易。公開市場賣出合計 $6.38 萬。交易後 16 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/16 | Common Stock | G贈與處分 | −500 | $0.00 | $0 | 22,591 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −1 | $631.15 | −$631.15 | 22,590 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −7 | $632.63F2 | −$4,428.41 | 22,583 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −2 | $633.47F3 | −$1,266.94 | 22,581 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −11 | $634.56F4 | −$6,980.16 | 22,570 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −9 | $635.36F5 | −$5,718.24 | 22,561 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −1 | $636.50 | −$636.5 | 22,560 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −22 | $637.75F6 | −$14,030.5 | 22,538 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −12 | $638.62F7 | −$7,663.44 | 22,526 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −24 | $639.49F8 | −$15,347.76 | 22,502 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −5 | $640.47F9 | −$3,202.35 | 22,497 | 直接 | |
| 2021/12/1 | Common Stock | S賣出處分 | −6 | $641.23F10 | −$3,847.38 | 22,491 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 7 shares of Company stock on December 1, 2021 at prices ranging from $632.00 to $632.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 2 shares of Company stock on December 1, 2021 at prices ranging from $633.21 to $633.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 11 shares of Company stock on December 1, 2021 at prices ranging from $634.05 to $634.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 9 shares of Company stock on December 1, 2021 at prices ranging from $635.06 to $635.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 22 shares of Company stock on December 1, 2021 at prices ranging from $637.17 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 12 shares of Company stock on December 1, 2021 at prices ranging from $638.03 to $638.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 24 shares of Company stock on December 1, 2021 at prices ranging from $639.01 to $639.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 5 shares of Company stock on December 1, 2021 at prices ranging from $640.01 to $640.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents volume-weighted average price of sales of 6 shares of Company stock on December 1, 2021 at prices ranging from $641.01 to $641.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。